![Martin Tolar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Tolar
Gründer bei
ALZHEON, INC.
Profil
Martin Tolar is the founder of Alzheon, Inc., founded in 2013, serving as President, Chief Executive Officer & Director.
Former jobs include President & CEO at NormOxys, Inc. from 2009 to 2011; President, Chief Executive Officer & Director at Tafkak, Inc. in 2012; Director at BELLUS Health, Inc. in 2010; Independent Non-Executive Director at Suven Life Sciences Ltd. from 2011 to 2013; Principal at Pfizer Inc.; Chief Scientific Officer at CoMentis, Inc.; and Assistant Professor at Yale School of Medicine.
Education includes doctorates from the University of Cincinnati (Ohio) and the University of Charles.
Aktive Positionen von Martin Tolar
| Unternehmen | Position | Beginn |
|---|---|---|
| ALZHEON, INC. | Gründer | 01.06.2013 |
Ehemalige bekannte Positionen von Martin Tolar
| Unternehmen | Position | Ende |
|---|---|---|
| BELLUS HEALTH | Direktor/Vorstandsmitglied | 27.09.2017 |
| SUVEN LIFE SCIENCES LIMITED | Direktor/Vorstandsmitglied | 16.01.2013 |
Tafkak, Inc.
 Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome sequencing and analysis solutions | Vorstandsvorsitzender | 01.10.2012 |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule therapeutics for the treatment of cancer | Vorstandsvorsitzender | - |
Ausbildung von Martin Tolar
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
27
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
BELLUS Health, Inc.
 BELLUS Health, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of refractory chronic disease | Health Technology |
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule therapeutics for the treatment of cancer | Health Technology |
Tafkak, Inc.
Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome sequencing and analysis solutions | Commercial Services |
Alzheon, Inc.
 Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
Suven Life Sciences Ltd.
 Suven Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drug intermediates and chemicals | Health Technology |
University of Cincinnati (Ohio)
 University of Cincinnati (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Charles
 University of Charles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CoMentis, Inc.
 CoMentis, Inc. Pharmaceuticals: MajorHealth Technology Focuses on developing drugs to treat various central nervous system disorders | Health Technology |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
